Steven Eliscu

UBS analysts Uche Orji and Steven Eliscu reiterated their Buy ratings for shares of Altera Corporation (Nasdaq: ALTR), with a price target of $29, and Xilinx, Inc. (Nasdaq: XLNX), with a price target of $31. The analysts believe the share price reaction of the two stocks to news of China capex cuts...